Vaccination in MS
Choosing a flexible treatment approach that adapts to other healthcare needs, such as vaccination protocols, is becoming increasingly important in the management of MS.1 By altering immune cell counts, the use of some DMTs can affect vaccination effectiveness and patient’s immunisation readiness and should therefore be carefully considered when making treatment decisions.2
Watch the videos below to find out more about vaccination!
Vaccination Video with Prof. Montalban
CONTINUE WATCHING
Multiple Sclerosis and COVID-19
CONTINUE WATCHING
Immunodepressed Patients
CONTINUE WATCHING
Vaccination of Immunosuppressed Patients
CONTINUE WATCHING
Type of Vaccines
CONTINUE WATCHING
Vaccination and MS: Risk and Effect
CONTINUE WATCHING
Pneumococcal Disease
CONTINUE WATCHING
Influenza Virus
CONTINUE WATCHING
Varicella Zoster Virus
CONTINUE WATCHING
HPV-related Cancer
CONTINUE WATCHING
Travel Vaccination of Immunosuppressed Travellers
YOU MAY ALSO LIKE
Biogen-140899.
Date of preparation: November 2021.
References:
1. Pardo G, Jones DE. The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. J Neurol. 2017;264(12):2351-2374.
2. Giovannoni G, Smets I, Reyes S. MS Minute: The COVID-19 Vaccine & Vaccine Readiness in MS. Pract Neurol. 2021:77-81.